Roupen Odabashian

Investor profile

Roupen Odabashian

Syndicate / Angel group, Venture capital & Fellow at HaloHealth, Due Diligence Lead at HealthTech Investors

Roupen Odabashian is a Due Diligence Lead at HealthTech Investors, whose known portfolio counts 10 companies.

Is Roupen Odabashian a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

LinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Fellow at HaloHealth, whose known portfolio counts 5 companies

  • Steadiwear
  • RetinaLogik
  • The Bird & Be Co.
  • Clinify
  • UVX

Due Diligence Lead at HealthTech Investors, whose known portfolio counts 10 companies

  • Journey Live
  • Joylux
  • Wavely Diagnostics
  • ManagingLife
  • S2 Genomics
  • Sinaptica Therapeutics
  • xCures
  • GT Metabolic Solutions
  • Junum
  • Radius XR

Investor Profile

Founders in the listed sectors AI, Hardware and Healthcare, and focus areas Biotech, Clinical-Founders, Diagnostics and Digital Health fall inside that listing.

Stage-wise, the deals at HealthTech Investors cluster around Pre-Seed, Seed and Series A rounds.

The firm portfolio and the focus above give founders context on whether Roupen Odabashian matches their raise.

Colleagues

Frequently asked questions

Who is Roupen Odabashian?

Roupen Odabashian is a syndicate member and venture capital investor based in United States, listed as Due Diligence Lead at HealthTech Investors. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Roupen Odabashian personally.

What does Roupen Odabashian invest in?

Listed sectors include AI, Hardware and Healthcare; listed focus areas include Biotech, Clinical-Founders, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Roupen Odabashian invest at?

HealthTech Investors appears in Pre-Seed, Seed and Series A rounds across its known deals, and Roupen Odabashian is listed there as Due Diligence Lead. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Roupen Odabashian listed at?

Roupen Odabashian is listed as Due Diligence Lead at HealthTech Investors. 3 other people in the database share a firm with Roupen Odabashian.

How do I contact Roupen Odabashian?

A LinkedIn page is on file for Roupen Odabashian. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal